OFI Invest Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
CIM
ATO
CGH
OFI Invest Asset Management's GILD Position: Q2 2026 in Review
OFI Invest Asset Management reduced its Gilead Sciences (GILD) stake by 3.9% in Q2 2026, selling an estimated $1.66M and leaving 307,767 shares worth $34.1M. The position accounts for 0.34% of the portfolio, ranked #68.
OFI Invest Asset Management first reported a position in GILD in Q1 2023 and has held it in 12 quarters since. The position peaked at $88.8M in Q4 2025. 759 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- OFI Invest Asset Management held 307,767 shares of Gilead Sciences worth $34.1M as of Q2 2026.
- OFI Invest Asset Management sold 12,567 Gilead Sciences shares in Q2 2026, an estimated $1.66M.
- Gilead Sciences made up 0.34% of OFI Invest Asset Management's portfolio in Q2 2026, its #68 holding.
- OFI Invest Asset Management first reported a position in Gilead Sciences in Q1 2023 and has held it in 12 quarters since.
- OFI Invest Asset Management's Gilead Sciences position peaked at $88.8M in Q4 2025.
- 759 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.